Hematology Analyzers and Reagents Market Report by Product (Haematology, Haemostasis, Immunohaematology), Usage Type (Standalone, Point-of-Care), Price Range (Low Range, Mid-Range, High Range), Application (Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia), End User (Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, and Others), and Region 2024-2032

Hematology Analyzers and Reagents Market Report by Product (Haematology, Haemostasis, Immunohaematology), Usage Type (Standalone, Point-of-Care), Price Range (Low Range, Mid-Range, High Range), Application (Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia), End User (Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A8300
Buy Now

Market Overview: 

The global hematology analyzers and reagents market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.94% during 2024-2032. Rising prevalence of blood disorders, the growing geriatric population, rapid advancements in technology, surging demand for point-of-care testing (POCT) devices and portable hematology analyzers, and the increasing adoption of automated hematology analyzers in laboratories and hospitals are some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 8.8 Billion
Market Forecast in 2032
US$ 15.0 Billion
Market Growth Rate 2024-2032 5.94%


Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems. 

Hematology Analyzers and Reagents Market Trends:

The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hematology analyzers and reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, usage type, price range, application, and end user.

Product Insights:

  • Haematology
  • Haemostasis
  • Immunohaematology
     

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the product. This includes haematology, haemostasis, and immunohaematology. According to the report, haematology represented the largest segment.

Usage Type Insights:

  • Standalone
  • Point-of-Care
     

A detailed breakup and analysis of the hematology analyzers and reagents market based on the usage type has also been provided in the report. This includes standalone and point-of-care. According to the report, standalone accounted for the largest market share.

Price Range Insights:

  • Low Range
  • Mid-Range
  • High Range
     

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the price range. This includes low range, mid-range, and high range. According to the report, low range represented the largest segment.

Application Insights:

  • Haemorrhagic Conditions
  • Infection-Related Conditions
  • Immune System-Related Conditions
  • Blood Cancer
  • Anaemia
     

A detailed breakup and analysis of the hematology analyzers and reagents market based on the application has also been provided in the report. This includes haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia. According to the report, haemorrhagic conditions accounted for the largest market share.

End User Insights:

  • Commercial Service Providers
  • Hospital Laboratories
  • Research and Academic Institutes
  • Others
     

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the end user. This includes commercial service providers, hospital laboratories, research and academic institutes, and others. According to the report, commercial service providers represented the largest segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for hematology analyzers and reagents. Some of the factors driving the North America hematology analyzers and reagents market included the surging demand for personalized medicine and companion diagnostics, the increasing number of clinical trials and drug development activities, and the rising demand for hematology analyzers and reagents in veterinary diagnostics.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global hematology analyzers and reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Product
  • Usage Type
  • Price Range
  • Application
  • End User
  • Region
Products Covered Haematology, Haemostasis, Immunohaematology
Usage Types Covered Standalone, Point-of-Care
Price Ranges Covered Low Range, Mid-Range, High Range
Applications Covered Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia
End Users Covered Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global hematology analyzers and reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hematology analyzers and reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global hematology analyzers and reagents market?
  • What are the key regional markets? 
  • Which countries represent the most attractive hematology analyzers and reagents market?
  • What is the breakup of the market based on product?
  • Which is the most attractive product in the hematology analyzers and reagents market?
  • What is the breakup of the market based on the usage type?
  • Which is the most attractive usage type in the hematology analyzers and reagents market?
  • What is the breakup of the market based on price range?
  • Which is the most attractive price range in the hematology analyzers and reagents market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the hematology analyzers and reagents market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the hematology analyzers and reagents market?
  • What is the competitive structure of the global hematology analyzers and reagents market?
  • Who are the key players/companies in the global hematology analyzers and reagents market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the hematology analyzers and reagents market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global hematology analyzers and reagents market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the hematology analyzers and reagents industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.  

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Hematology Analyzers and Reagents Market Report by Product (Haematology, Haemostasis, Immunohaematology), Usage Type (Standalone, Point-of-Care), Price Range (Low Range, Mid-Range, High Range), Application (Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia), End User (Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More